TWiV 1018: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses the CDC vaccine advisory group recommending the newly approved RSV vaccines, association of culturable-virus detection and household transmission of SARS-CoV-2, prevention of COVID-19 following a single intramuscular administration of Adintrevimab, real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19, and COVID-19 convalescent plasma outpatient therapy to prevent outpatient hospitalization. Subscribe (free): Apple Podcasts , Google Podcasts , RSS , email Become a patron of TWiV! Links for this episode CDC vaccine advisory group recommends RSV vaccines Association of culturable-virus detection and household transmission of SARS-CoV-2 (JID) Prevention of COVID-19 following intramuscular administration of Adintrevimab (OFID) Real-world effectiveness of Nirmatrelvir/Ritonavir on COVID-19 (CID) COVID-19 convalescent plasma outpatient therapy to prevent hospitalization (CID) Contribute to our FIMRC fundraiser at PWB Letters read on TWiV 1018 Dr. Griffin's COVID treatment summary ( pdf ) Timestamps by Jolene . Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]